News from us and our partners

Tags

Topics

0 results

News
20 April, 2023
Sofinnova Partners appoints Mary McCarthy as Partner for the firm’s Industrial Biotech Strategy
News
17 April, 2023
Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis
News
17 April, 2023
Alia Therapeutics secures €4.4 million seed financing extension led by Sofinnova Partners
News
12 April, 2023
Maestro Surgical Robotics System by Moon Surgical, Now CE Marked
News
11 April, 2023
Catamaran Bio Announces Preclinical Data from Allogeneic CAR-NK Cell Therapy Pipeline for Solid Tumors to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2023
News
5 April, 2023
Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
News
31 March, 2023
Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD
News
30 March, 2023
Landmark New England Journal of Medicine publication reports positive results from PROMISE II pivotal trial showing that LimFlow System saves most patients with end-stage peripheral artery disease from major amputation
News
28 March, 2023
Kiro, cutting-edge digital medicine company, raises €13.8 million in Series A funding led by Sofinnova Partners
News
28 March, 2023
Digital Medicine pioneer, deepc, announces €12 million Series A round led by Sofinnova Partners
News
28 March, 2023
Sofinnova Partners launches Digital Medicine Strategy
News
28 March, 2023
BioCorteX raises $5M, led by Sofinnova
News
24 March, 2023
Microphyt appoints two new directors and confirms its focus on sustainable value creation with a new ESG Advisory Committee
News
15 March, 2023
Mediar Therapeutics announces $105 million financing to advance portfolio of first-in-class fibrosis therapies
News
13 March, 2023
Calliditas announces primary endpoint successfully met in Phase 3 NefIgArd trial evaluating Nefecon® in IgA nephropathy
News
7 March, 2023
Enthera initiates Phase 1 trial of Ent001 in healthy volunteers

Sofinnova Partners appoints Mary McCarthy as Partner for the firm’s Industrial Biotech Strategy

Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis

Alia Therapeutics secures €4.4 million seed financing extension led by Sofinnova Partners

Maestro Surgical Robotics System by Moon Surgical, Now CE Marked

Catamaran Bio Announces Preclinical Data from Allogeneic CAR-NK Cell Therapy Pipeline for Solid Tumors to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2023

Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair

Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD

Landmark New England Journal of Medicine publication reports positive results from PROMISE II pivotal trial showing that LimFlow System saves most patients with end-stage peripheral artery disease from major amputation

Kiro, cutting-edge digital medicine company, raises €13.8 million in Series A funding led by Sofinnova Partners

Digital Medicine pioneer, deepc, announces €12 million Series A round led by Sofinnova Partners

Sofinnova Partners launches Digital Medicine Strategy

BioCorteX raises $5M, led by Sofinnova

Microphyt appoints two new directors and confirms its focus on sustainable value creation with a new ESG Advisory Committee

Mediar Therapeutics announces $105 million financing to advance portfolio of first-in-class fibrosis therapies

Calliditas announces primary endpoint successfully met in Phase 3 NefIgArd trial evaluating Nefecon® in IgA nephropathy

Enthera initiates Phase 1 trial of Ent001 in healthy volunteers